Nautilus Biotechnology, Inc. NAUT
2.23 USD +0.08 (+3.72%)
At closeNov 6, 2026, 7:51 PM EST
2.25 +0.02 +0.90%
After hours · Nov 6, 7:51 PM ET
2.06 Day range 2.29
0.852 52-week range 3.95
- YTD
- +14.36%
- 1 year
- +47.68%
Financial health
Altman Z-Score
1.05 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Rating
C2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 3
- P/E 1
- P/B 4
Valuation
P/E -4.1×
FY 2018 5y median -4.1× FY 2025
P/S 0.0×
FY 2018 5y median 0.0× FY 2025
P/B 1.6×
FY 2018 5y median 1.2× FY 2025
P/FCF -4.7×
FY 2018 5y median -4.7× FY 2025
EV/EBITDA -5.0×
FY 2018 5y median -5.0× FY 2025
EV/Sales 0.0×
FY 2018 5y median 0.0× FY 2025
FCF Yield -21.1%
FY 2018 5y median -21.1% FY 2025
Profitability
Gross Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2018 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2018 5y median 0.0% FY 2025
ROE -37.6%
FY 2018 5y median -24.0% FY 2025
ROIC -35.7%
FY 2018 5y median -25.4% FY 2025
ROA -30.9%
FY 2018 5y median -20.8% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2018 FY 2025
Operating Income 18.0%
FY 2018 FY 2025
EPS (diluted) 16.1%
FY 2018 FY 2025
Free Cash Flow 15.2%
FY 2018 FY 2025
Financial Health
Current Ratio 13.3×
FY 2018 5y median 19.4× FY 2025
Quick Ratio 13.3×
FY 2018 5y median 19.4× FY 2025
Debt / Equity 0.2×
FY 2018 5y median 0.1× FY 2025
Net Debt / EBITDA -0.3×
FY 2018 5y median -0.0× FY 2025
Interest Coverage 0.0×
FY 2018 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31